• Home
  • About Us

Idiopathic Pulmonary Fibrosis

Jeremy Feldman, MD

  • What is Idiopathic Pulmonary Fibrosis?
    • Idiopathic Pulmonary Fibrosis Definition
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy and Prognosis for Idiopathic Pulmonary Fibrosis
  • Diagnosing & Monitoring PF
    • Monitoring Progress of IPF
    • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis
  • PF Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
      • Update on Oxygen Use
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation
  • PF Advocacy & News
  • FAQ’s
    • Respiratory failure, NSIP, diet
    • Leg swelling, lung biopsy, side effects & pets
    • FAQ’s Enzyme Therapy, Progression of IPF & Oxygen
    • FAQ: Diarrhea, Fibrosis Reversal, IPF Symptoms
    • FAQ: Oxygen Flow, Anesthesia & Genetics
    • FAQ: Contagious Cough? Stem Cells, Familial IPF, Flying
    • FAQ: GERD, Fatigue & Environmental Exposure
    • FAQ: How to Travel to Your Doctor’s Office with Oxygen
    • FAQ: Lung Biopsy with Pulmonary Fibrosis
    • FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing
    • FAQs: Emphysema, Exercise & Lung Biopsy

Knowledge is Power. Learn More & Breathe Better.

Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis MD is an educational resource for patients, caregivers, friends, and family members interested in learning about Idiopathic Pulmonary Fibrosis or IPF.

Idiopathic Pulmonary Fibrosis

It is an exciting time for the Pulmonary Fibrosis community because new treatments are currently being researched and approved. Pulmonologist Jeremy Feldman, MD has devoted his career to treating patients with advanced lung diseases such as IPF and has developed this educational resource to help educate the community and provide the most up to date information on living with and treating Idiopathic Pulmonary Fibrosis.

This site provides information on:

  • Idiopathic Pulmonary Fibrosis Definition
  • Symptoms of Idiopathic Pulmonary Fibrosis
  • Idiopathic Pulmonary Fibrosis Diagnosis
  • Treatment for Idiopathic Pulmonary Fibrosis
  • Life Expectancy and Prognosis for Idiopathic Pulmonary Fibrosis

We strive to provide a comprehensive base of information about Pulmonary Fibrosis, as well as current and niche topics that we cover in the blog posts. Our aim is to provide a unique and real life perspective on the issues that IPF patients face. Topics may include traveling with IPF, exercise, pulmonary rehabilitation, oxygen tips, medications, transplant, conditions related to IPF, vaccination, and much more. We try to address the practical every day issues real patients and caregivers are struggling with. Search our blog posts and chances are we’ve written about it.

All information on this site is written & edited by an MD or RN  specializing in advanced lung diseases such as Idiopathic Pulmonary Fibrosis.

The Latest Articles

IPF CT Scan | Expiration-Supine

New Drugs Moving Forward for IPF

July 18, 2022 By Dr. Jeremy Feldman

BI 1015550 The past few months have brought very exciting news for IPF patients.  A novel drug being developed by Boehringer Ingelheim (BI 1015550) showed positive results in a phase 2 study.  This new medication blocks the phosphodiesterase 4B receptor.  Blockade of this receptor has shown promise in animal models by causing reduced inflammation and […]

Exercise with IPF

FAQs: Emphysema, Exercise & Lung Biopsy

August 26, 2020 By Dr. Jeremy Feldman

Dr. Feldman addresses some common questions below. I have pulmonary fibrosis and emphysema.  Why am I so short of breath? Emphysema is often a smoking related lung disease.  The air sacs are destroyed and the lung tissue starts to look like Swiss cheese.  Pulmonary fibrosis replaces the normal lung tissue with scar formation, especially in the lower lobes.  In […]

wine with pulmonary fibrosis

FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing

July 20, 2020 By Dr. Jeremy Feldman

The past few months have been particularly stressful both in the United States and across the world.  As COVID-19 has barreled across the globe, our usual routines have been upended.  At PulmonaryFibrosisMD.com we have worked to keep our readers current on major developments.  Many of our readers have submitted questions that we will try and address.  As always, we […]

Pulmonary Fibrosis and Pulmonary Hypertension – a New Treatment Option

April 22, 2020 By Dr. Jeremy Feldman

United Therapeutics announced positive results of their study looking at the role of Tyvaso in patients with pulmonary fibrosis and pulmonary hypertension.  This is a landmark event.  No study to date has shown positive results in this population.  Patients with interstitial lung disease (broad category of lung disorders involving scarring of the lungs) of any etiology were […]

Featured Blog Posts

Research Updates for Pulmonary Fibrosis – June 2017

prescription for Ofev (nintedanib)

Managing OFEV Side Effects

Beware: Unapproved Treatments for IPF

Recent Posts

  • New Drugs Moving Forward for IPF
  • FAQs: Emphysema, Exercise & Lung Biopsy
  • FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing

Search by Keyword (Examples: GERD, Coughing, Traveling, etc.)

Search by Category

Popular Articles

IPF patient with doctor

Idiopathic Pulmonary Fibrosis Treatment Options

What is IPF?

  • What is Idiopathic Pulmonary Fibrosis?
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and IPF
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy & Prognosis for Pulmonary Fibrosis

Diagnosing IPF

  • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis

Treating IPF

  • Pulmonary Fibrosis Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation

Disclaimer